In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: LivaNova PLC appears significantly overvalued, with current price at $80.70 versus a high-confidence fair value of $40.35 and implied downside of 50%. DCF shows negative valuation, while market-based metrics suggest moderate value, indicating valuation discrepancies. Financial health reveals strong leverage and growth but weak profitability and efficiency, heightening risk despite zero downside in scenario analysis.